These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 17392175)
1. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Cui H; Hu B; Li T; Ma J; Alam G; Gunning WT; Ding HF Am J Pathol; 2007 Apr; 170(4):1370-8. PubMed ID: 17392175 [TBL] [Abstract][Full Text] [Related]
2. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells. Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425 [TBL] [Abstract][Full Text] [Related]
3. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782 [TBL] [Abstract][Full Text] [Related]
4. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3. Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085 [TBL] [Abstract][Full Text] [Related]
5. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. Song L; Ara T; Wu HW; Woo CW; Reynolds CP; Seeger RC; DeClerck YA; Thiele CJ; Sposto R; Metelitsa LS J Clin Invest; 2007 Sep; 117(9):2702-12. PubMed ID: 17710228 [TBL] [Abstract][Full Text] [Related]
6. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Kang JH; Rychahou PG; Ishola TA; Qiao J; Evers BM; Chung DH Biochem Biophys Res Commun; 2006 Dec; 351(1):192-7. PubMed ID: 17055458 [TBL] [Abstract][Full Text] [Related]
7. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183 [TBL] [Abstract][Full Text] [Related]
8. Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells. Wang Q; Li WL; You P; Su J; Zhu MH; Xie DF; Zhu HY; He ZY; Li JX; Ding XY; Wang X; Hu YP J Cell Biochem; 2009 Jan; 106(1):16-24. PubMed ID: 19021148 [TBL] [Abstract][Full Text] [Related]
9. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167 [TBL] [Abstract][Full Text] [Related]
10. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells. Smith AG; Popov N; Imreh M; Axelson H; Henriksson M J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910 [TBL] [Abstract][Full Text] [Related]
11. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436 [TBL] [Abstract][Full Text] [Related]
12. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression. Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304 [TBL] [Abstract][Full Text] [Related]
13. MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis. Slack A; Lozano G; Shohet JM Cancer Lett; 2005 Oct; 228(1-2):21-7. PubMed ID: 15927364 [TBL] [Abstract][Full Text] [Related]
14. Histological profile of tumours from MYCN transgenic mice. Moore HC; Wood KM; Jackson MS; Lastowska MA; Hall D; Imrie H; Redfern CP; Lovat PE; Ponthan F; O'Toole K; Lunec J; Tweddle DA J Clin Pathol; 2008 Oct; 61(10):1098-103. PubMed ID: 18682419 [TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178 [TBL] [Abstract][Full Text] [Related]
16. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation. Koppen A; Ait-Aissa R; Hopman S; Koster J; Haneveld F; Versteeg R; Valentijn LJ Cancer Lett; 2007 Oct; 256(2):218-28. PubMed ID: 17643814 [TBL] [Abstract][Full Text] [Related]
17. Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN. Koppen A; Ait-Aissa R; Koster J; Øra I; Bras J; van Sluis PG; Caron H; Versteeg R; Valentijn LJ Int J Cancer; 2008 Apr; 122(7):1455-64. PubMed ID: 18059033 [TBL] [Abstract][Full Text] [Related]
18. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model. Blanc E; Goldschneider D; Ferrandis E; Barrois M; Le Roux G; Leonce S; Douc-Rasy S; Bénard J; Raguénez G Am J Pathol; 2003 Jul; 163(1):321-31. PubMed ID: 12819037 [TBL] [Abstract][Full Text] [Related]
19. Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. Cui H; Ma J; Ding J; Li T; Alam G; Ding HF J Biol Chem; 2006 Nov; 281(45):34696-704. PubMed ID: 16982619 [TBL] [Abstract][Full Text] [Related]
20. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]